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ABSTRACT 
The present study was undertaken to evaluate the effect of Azadirachta indica leaves extract on wound healing activity in normal 
and streptozotocin-induced diabetic rats. Methanolic extract ointment was applied on excised wounds in healthy non diabetic and 
streptozotocin induced diabetic rats. This exhibited significant increase in mean percentage wound contraction and tensile strength in 
excision and dead Space wound models respectively, in both normal and diabetic rats when compared with control. The extract 
promoted wound contraction, reduced the wound closure time and induced proliferation of fibroblast as well as angiogenesis and re-
epithelialization. 
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INTRODUCTION 
Diabetes mellitus, which is a morose condition 
associated with various connective tissue (mainly 
collagen tissue) abnormalities, is generally associated 
with delayed wound healing. Delay in wound healing, 
specifically to diabetic patients, is due to ill 
function/metabolic behavior/chemotaxis of leucocytes 
resulting in non-availability of neutrophils and 
macrophages to the wound
1
. Wound healing is to reduce 
tissue damage by providing satisfactory blood supply, 
oxygenation, proper nutrition and moist environment for 
healing of the wound
2
. It involves the planned and 
coordinated interaction between extracellular matrix, 
different types of cells (leukocytes, fibroblasts etc.) and 
various growth factors such as platelet derived growth 
factor, epidermal growth factor, fibroblast growth factor 
etc. Delayed wound healing is producing high economic 
burden on the society.  
Azadirachta indica (Meliaceae), commonly known as 
Neem is cultivated widely in tropical areas of the world. 
Its various parts reported to have anti-inflammatory, 
antipyretic, neuropsychological, antimicrobial, 
antimycotic, cardiovascular, immunomodulatory, anti-
hyperglycemic activity. Azadirachta indica used as folk 
medicine to control leprosy, intestinal helminthiasis, 
respiratory disorders and constipation
3
. (Kirtikar, 1935) 
This study is proposed to evaluate and compare the 
cutaneous wound healing potential of Azadirachta 
indica in normal and diabetic rats and make inference 
for the cutaneous wound healing potential by possible 
“Mode of action” of Azadirachta indica extract. There is 
no significant work done in management of diabetic 
wound complication of the plant Azadirachta indica. 
 
Jain et al                                                                                                             Journal of Drug Delivery & Therapeutics. 2018; 8(4):277-281           
ISSN: 2250-1177                                                                             [278]                                                                             CODEN (USA): JDDTAO 
MATERIALS AND METHODS 
Plant material and extraction 
The leaves of Azadirachta indica were collected from 
the medicinal garden of IPS Group of Colleges, Gwalior 
(M.P.)in December, 2013 from healthy plants and 
herbarium was prepared and authenticated by Dr. A. K. 
Jain, Head, Department of Botany, Jiwaji University, 
Gwalior(M.P.).Plant leaves was dried under shade and 
coarsely powdered. Dried powder of drug was then 
extracted with petroleum ether, chloroform and 
methanol for 2 h at their boiling point temperatures in 
soxhlet apparatus. The extracts were concentrated with a 
rotary evaporator (Jyoti scientific, Gwalior), freeze dried 
and stored in refrigerator until used.  
Preliminary Phytochemical Tests 
The crude extracts of Azadirachta indica was subjected 
to qualitative tests for identification of different 
constituents like alkaloids, flavonoids, terpenoids, 
phenolics, glycosides, saponins and tannins by using 
standard qualitative methods described by Trease and 
Evans
4
.  
Chemical  
Streptozotocin (STZ) was purchased from Sigma 
chemical company. All other chemicals used in the 
experiments were purchased locally and were of 
analytical grade.  
Animals 
Wistar albino rats (150-200 g) of either sex were 
selected. The animals were housed in polypropylene 
cages under standard conditions (25±5% °C, 12 h light 
and dark cycle) with free access to standard pellet feed 
and water ad libitum. All the experimental procedures 
and protocols were approved by the Institutional 
Animals Ethics Committee (Proposal no. 
IPS/COP/IAEC/04, dated 30/09/2014) as per CPCSEA 
guidelines. The animals were used for experimentation 
after one week of acclimatization period. 
Preliminary Pharmacological Screening of Extracts 
Excision wound model was selected to access the 
wound healing capability of plant extracts. Semisolid 
ointment formulations were prepared of all successive 
extracts. The animals were divided into five groups 
(n = 6) and treated topically twice a day. 
Group I: Control treated with simple ointment base  
Group II:  standard treated with 0.005% Fluticasone 
propionate 
Group III: Treated with chloroform extract ointment  
Group IV: Treated with methanol extract ointment  
Group V: Treated with pet ether extract ointment  
Formulation of ointments  
Ointment base was prepared by levigation method using 
prescribed amount of wool fat, cetostearyl alcohol, hard 
paraffin and yellow soft paraffin. This served as control 
base and dried Methanolic Azadirachta indica (MAI) 
extracts were added to the ointment base to obtain 
2.5%(w/w) (F1) and 5% (w/w) (F2) concentration. 
Fluticasone propionate (Glaxo SmithKline, India) 
ointment was used as standard for positive control. 
Diabetes induction  
Diabetes was induced in overnight fasted rats by 
intraperitoneal injection of freshly prepared solution of 
streptozotocin (50 mg/kg body weight) in 0.1 M citrate 
buffer (pH 4.5). Wounds were made on the rats showing 
elevated blood glucose level (250mg/dl). 
Wound healing study  
Excision wound model  
The animals were divided into eight groups (n = 6) and 
treated topically once a day, starting from wound 
induction until complete healing.  
Group 1: Non-Diabetic control (treated with ointment 
base)  
Group 2: Non-Diabetic Standard (treated with 
Fluticasone propionate (0.005% w/w))  
Group 3: Diabetic control (treated with ointment base) 
Group 4: Diabetic Standard (treated with Fluticasone 
propionate (0.005% w/w)) 
Group 5: Non-Diabetic wounds treated with 2.5% w/w 
methanol extract ointment 
Group 6: Non-Diabetic wounds treated with 5% w/w 
methanol extract ointment 
Group 7: Diabetic wounds treated with 2.5% w/w 
methanol extract ointment 
Group 8: Diabetic wounds treated with 5% w/w 
methanol extract ointment 
Streptozotocin induced diabetic wistar albino rats of 
either sex were anesthetized with intraperitoneal 
injection of ketamine (50 mg/kg body weight) and their 
dorsal surface was shaved with a sterile blade. The 
shaved area was disinfected with 70% (v/v) ethanol. 
One full thickness circular excision wound (14 mm 
diameter) was created on the dorsal middle line. Wound 
contraction was measured as percent contraction in each 
two days after wound formation
5
. 
Dead space wound model  
This model was used for the study of granuloma tissue. 
The animals were grouped as mentioned in excision 
modeland anaesthetized by light ether and wound was 
made by implantation of polypropylene tube (2.0 x 0.5), 
in the lumber region on the dorsal surface in each 
animal. On the 10
th
 post-wounding day, granuloma 
tissue formed on implanted tube was dissected out 
carefully. Granuloma tissue was used for determination 
of tensile strength
6-7
.  
Statistical analysis 
All the results are expressed as mean standard error of 
mean (SEM). Statistical analysis was performed using 
one-way ANOVA followed by student t-test. Data were 
considered significant at P< 0.05. 
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RESULTS 
Phytochemical analysis  
The phytochemical analysis of crude extracts of 
Azadirachta indica leaves revealed the presence of 
coumarins, glycosides, tannins, alkaloids, saponins and 
flavonoids. The presences of these phytochemicals are 
considered to be responsible for wound healing activity 
in diabetes (Table 1). 
 
Table 1: Phytochemical screening of leaf extracts of Azadirachta indica 
S.No. Test for Plant Constituents Petroleum Ether Chloroform Methanol 
1.  Alkaloids 
Saponins 
carboxylic acids 
Flavanoides 
Resins 
Volatile oils 
Coumarins 
Xantho proteins 
Glycosides 
Tannins 
Fatty acids 
- 
+ 
- 
+ 
- 
+ 
+ 
- 
+ 
+ 
+ 
- 
- 
- 
+ 
- 
+ 
+ 
- 
+ 
+ 
+ 
+ 
+ 
- 
+ 
- 
+ 
+ 
- 
+ 
+ 
+ 
2.  
3.  
4.  
5.  
6.  
7.  
8.  
9.  
10.  
11.  
 
Preliminary Pharmacological Screening of Extracts 
Table 2: Percentage wound contraction by different extracts of Azadirachta indica in excision wound model in rats. 
 
All the extracts of Azadirachta indica showed a 
significant (P < 0.01) decrease in wound contraction 
when compared to control group. Methanol extract 
required less days (16) for complete wound healing. The 
standard drug treated animals showed significantly 
greater wound closure as compared to the extract treated 
animals. The results demonstrate (Table 2) potential 
wound healing property of the methanol extract. Further 
studies may be carried out on methanol extract in order 
to find out the various wound healing parameter in 
diabetic and non diabetic rats. 
Excision wound model  
It was observed that the methanol extracts in both the 
concentrations of 2.5% w/w and 5% w/w significantly (P 
< 0.01) reduced the epithelization time of animals. In 
diabetic animals, methanolic extracts showed 
significantly greater wound healing as comparative to 
diabetic control animals. Also in normal animals, the 
methanol extracts showed significantly greater wound 
healing when compared with normal control animals. 
The Calculation of wound contraction standard drug-
treated animals in both normal and diabetic animals was 
showed significantly greater wound closure when 
compared with control and extract-treated animals 
(Table 3 & 4). 
Dead space wound model 
Wound parameters 
In diabetic animals and normal animals, the methanol 
extracts in both the concentrations of 2.5% w/w and 5% 
w/w showed significantly higher levels of 
hydroxyproline when compared with control animals 
group. A significant increase was also observed in the 
dry and wet weight of the granulation tissue in the 
methanol extracts in both the concentrations of 2.5% 
w/w and 5% w/w when compares with control animals 
groups (Table 5 & 6). In diabetic animals, the methanol 
extracts in both the concentrations of 2.5% w/w and 5% 
w/w showed significantly greater tensile strength when 
compared with diabetic control animals (Table 7). 
Days    Simple ointment 
(control)   
Standard ointment 
(0.005% Fluticasone 
propionate) 
Chloroform 
extract 
ointment   
Methanol 
extract 
ointment  
Pet ether extract 
ointment  
4   
6   
8   
10   
12   
14     
16     
18   
20   
22      
24   
26   
39.22   
42.36   
53.12   
62.33   
69.45   
78.62   
85.18     
89.33     
96.98     
97.15     
99.15         
100 
28.65   
71.35   
85.06   
92.95   
98.52   
100 
54.68   
55.73   
68.35   
74.56   
82.17   
87.46   
93.37   
95.68     
98.44     
100 
50.67   
66.35   
78.81   
86.55   
94.18   
98.33   
100 
33.46 
55.15 
60.31 
67.76 
73.53 
81.27 
86.35 
97.61 
98.31 
99.91 
100 
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Table 3: Effect of extract and standard ointment on various wound parameters of Excision wound model in non-
diabetic rats 
Groups Control/ Formulation   
 
Hydroxyproline   
(mg/ g tissue)  
Protein content  
(mg/g tissue)  
Tensile strength      
(g/mm2)  
Epithelization  
period (days) 
I Control (Non- Diabetic)   35.25 51.67 3.87 25 
II Std. (Non- Diabetic)   64.85 71.68 5.24 17 
V F1 58.23 64.32 4.95 20 
VI F2 62.29 68.98 5.10 19 
 
Table 4: Effect of extract and standard ointment on various wound parameters of Excision wound model in diabetic rats 
Groups Control/ Formulation   Hydroxyproline   
(mg/ g tissue)  
Protein content  
(mg/g tissue)  
Tensile strength      
(g/mm2)  
Epithelization  
period (days) 
III Control (Diabetic)   22.94 43.55 1.96 29 
IV Std. ( Diabetic)   41.27 62.56 4.28 20 
VII F1 31.26 56.23 3.70 26 
VIII F2 38.29 60.26 3.98 22 
 
Table 5: Effect of extract and standard ointment on various wound parameters of dead space wound model in non-
diabetic rats 
Groups Control/ Formulation   
 
Hydroxyproline   
(mg/ g tissue)  
Protein content  
(mg/g tissue)  
Tensile strength      
(g/mm2)  
Granuloma dry  
weight (mg) 
I Control (Non- 
Diabetic)   
28.17   24.73   2.55   20.75 
II Std. (Non- Diabetic)   61.37   59.12   4.15   58.21 
V F1 41.65   38.27   3.15   51.27 
VI F2 60.59   57.11   3.95   57.25 
 
Table 6: Effect of extract and standard ointment on various wound parameters of dead space wound model in diabetic 
rats 
Groups Formulation Hydroxyproline 
(mg/ g tissue) 
Protein content 
(mg/g tissue) 
Tensile strength 
(g/mm2) 
Granuloma dry 
weight (mg) 
III Control (Diabetic) 15.27 16.68 1.24 13.56 
IV Std. (Diabetic) 51.36 42.81 3.13 57.43 
VII F1 37.15 31.55 2.64 47.82 
VIII F2 42.73 41.68 2.85 56.11 
 
 Table 7: Effect of prepared formulations and reference ointment on percent wound contraction on excision wound 
model in non-diabetic and diabetic rats. 
 
Non-Diabetic Diabetic 
Days 
Control (Non-
Diabetic) 
Std. (Non-
Diabetic) 
F1 F2 
Control 
(Diabetic) 
Std.  
(Diabetic) 
F1 F2 
4 28.67 54.68 50.56 52.67 15.32 50.71 44.15 45.85 
6 42.39 71.35 66.27 67.52 31.59 64.60 62.51 63.14 
8 53.16 85.06 78.76 80.53 44.36 80.58 77.64 78.95 
10 62.37 92.95 86.52 87.74 55.29 91.74 85.39 86.60 
12 69.50 98.52 94.17 96.26 63.74 96.93 92.28 93.99 
 
DISCUSSION 
Wound represents a major health problem, both in terms 
of morbidity and mortality.Diabetes is associated with 
delays in wound healing, which may be due to the 
elevation of blood glucose levels, denaturation of 
proteins and cellular components, overproduction of 
oxidative free radicals, and alterations in connective 
tissue metabolism, that is, loss of collagen
8
.Wound 
healing is characterized by three stages, viz., 
inflammation, proliferation, and remodeling. The 
proliferative phase typically demonstrates angiogenesis, 
collagen deposition, granulation tissue formation, 
epithelialization and wound contraction. Collagen is an 
extracellular protein in the granulation tissue of a 
healing wound and acts as a homeostatic agent as well 
as an initiator of epithelization by providing strength 
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and integrity to a tissue matrix. These alterations of 
collagen may be due to decreased levels of synthesis or 
enhanced catabolism of newly synthesized collagen, or 
both
9
. 
The topical application of prepared ointments of MAI 
improved the breaking strength, wound contraction, and 
period of epithelization in the excision and dead space 
models of experimental wounds. The faster wound 
contraction rate may be due to the stimulation of 
interleukin or induction of more rapid maturation of 
granulation tissue. A significant increase in collagen 
content due to the enhanced migration of fibroblasts and 
epithelial cells to the wound site was observed during 
the wound-healing process in the treated group. A close 
observation of granulation tissue sections revealed that 
tissue regeneration was much quicker in the treated 
group compared to diabetic control.  
The increase in dry granulation tissue weight in the 
treated groups indicated high protein content. Collagen 
is composed of the amino acid hydroxyproline, which 
has been used as a biochemical marker for tissue 
collagen
10
. In the dead space wound model, the increase 
of dry tissue weight and hydroxyproline content was 
observed in each treatment derived from MAI, which 
suggests greater deposition of collagen. The formation 
and maturation of collagen may be due to the presence 
of flavonoids and steroids in MAI, which are 
responsible for free radical-scavenging activities and 
help to promote the most important phase of wound 
healing. Hence, on the basis of results obtained and 
above facts, we can say that the faster wound healing 
activity of MAI in diabetic and normal animals may be 
due to the presence of phytochemicals and their effect 
on components of wound healing. 
CONCLUSION 
The present study concluded that the topical application 
of methanol extract of A. indica leaves applied topically 
promotes the healing of wounds, with enhanced rates of 
collagen turnover and wound contraction in diabetic-
induced rats. The results also show that application of 
methanol extract of A. indica leaves significantly 
increased dry and wet weight and hydroxyproline 
content in both normal and diabetic animals. 
On the basis of above, it may be conclude that plant 
extract promotes wound healing in both diabetic and 
normal animals by topical application of extracts. This 
supports its prevalent use in treatment of diabetes and 
infection.However, further phytochemical studies are 
needed to isolate the active compounds responsible for 
these pharmacological activities and will be helpful in 
projecting this plant as a therapeutic target for healing 
wounds and treating various diseases. 
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